Stockscreener 앱 받기
11.22
0.90%
0.12
Clearpoint Neuro Inc 주식(CLPT)의 최신 뉴스
Discipline and Rules-Based Execution in CLPT Response - Stock Traders Daily
ClearPoint Neuro to report first quarter 2026 results on May 13 - Traders Union
ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026 - ACCESS Newswire
ClearPoint Neuro schedules May 13 earnings call after market close - Stock Titan
ClearPoint Neuro, Inc. Q4 2025 earnings preview - MSN
ClearPoint Neuro: Temporary Headwinds Don't Change The Long-Term Outlook - Seeking Alpha
ClearPoint Neuro (CLPT) moves 8.1% higher: Will this strength last? - MSN
Here’s why biotech UniQure’s stock just tripled, and brought ClearPoint shares up with it - MSN
ClearPoint Neuro plunges as FY26 guidance falls below analysts' estimates - MSN
Clearpoint Neuro, Valneva, Rocket Lab and other big stocks moving lower in Wednesday's pre-market session - MSN
ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint - Chronicle-Tribune
ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint - News-Press NOW
Behavioral Patterns of CLPT and Institutional Flows - Stock Traders Daily
ClearPoint Neuro | DEFA14A: Others - Moomoo
[ARS] ClearPoint Neuro, Inc. SEC Filing - Stock Titan
ClearPoint Neuro completes first procedure with new drill system By Investing.com - Investing.com India
Lake Street Initiates ClearPoint Neuro(CLPT.US) With Buy Rating, Announces Target Price $30 - Moomoo
ClearPoint (CLPT): Buy, Sell, or Hold? | Q4 2025: Earnings Fall ShortCommunity Sell Signals - Cổng thông tin điện tử tỉnh Lào Cai
ClearPoint Neuro (CLPT) Achieves Milestone with New Surgical Dri - GuruFocus
ClearPoint Neuro completes first procedure with new drill system - Investing.com
ClearPoint Neuro wins FDA clearance for Velocity Alpha MR High Speed Surgical Drill System - Traders Union
ClearPoint's brain surgery drill gets FDA clearance, first clinical use - Stock Titan
Analysts Offer Insights on Healthcare Companies: Monopar Therapeutics Inc (MNPR), ClearPoint Neuro (CLPT) and CG Oncology, Inc. (CGON) - The Globe and Mail
CLPT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable - 富途牛牛
ClearPoint Neuro receives Canadian clearance for navigation system By Investing.com - Investing.com India
ClearPoint Neuro gets Canadian approval for navigation system - Investing.com
ClearPoint Neuro (NASDAQ:CLPT) Trading Down 5.3%Should You Sell? - MarketBeat
ClearPoint Neuro gets Canadian approval for navigation system By Investing.com - Investing.com India
ClearPoint Neuro receives Canadian clearance for navigation system - Investing.com
ClearPoint Neuro (CLPT) Receives Medical Device License from Hea - GuruFocus
ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug De - PharmiWeb.com
Bigger Capital Group (CLPT) files ownership update showing 7.54% attributed to Michael Bigger - Stock Titan
Canadian regulators clear ClearPoint Neuro navigation system, expanding device reach - Traders Union
Canada clears ClearPoint brain navigation system for clinical trial sites - Stock Titan
ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint | FinancialContent - FinancialContent
(CLPT) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
0.76%
0.72%
자본화:
|
볼륨(24시간):